Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.4) was added to the study history, and the previous revision (v3.6.3) was removed, representing an update to the record version.
    Difference
    0.1%
    Check dated 2026-07-24T12:22:10.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, is added to the study record history. The previous revision, v3.6.2, is removed from the history, updating the version trail for this record.
    Difference
    0.1%
    Check dated 2026-07-03T15:08:06.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The revision history now shows a newer release (v3.6.2) and replaces the older v3.6.0 entry, reflecting a maintenance update to the page's versioning.
    Difference
    0.1%
    Check dated 2026-06-26T20:27:11.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study record history now shows new labels 'Last verified' and 'Last known status was' and adds a new revision entry 'Revision: v3.6.0'; the older labels 'Verified' and 'Last known status was:' plus the older 'Revision: v3.5.5' are removed from this view.
    Difference
    3%
    Check dated 2026-06-12T23:00:37.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The Record History now lists Revision: v3.5.5 as the latest entry in the Study Record Versions. The previous Revision: v3.5.4 entry has been removed.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:05.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The page revision label now reads v3.5.4, replacing the previous v3.5.3; this indicates a minor metadata update without altering the study content or data.
    Difference
    0.2%
    Check dated 2026-05-15T15:23:53.000Z thumbnail image

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.